background
develop
plantbas
vaccin
plasmodium
vivax
two
p
vivax
candid
protein
chosen
first
merozoit
surfac
major
asexu
blood
stage
antigen
current
consid
strong
vaccin
candid
second
circumsporozoit
protein
csp
compon
sporozoit
contain
bcell
epitop
method
synthet
chimer
recombin
bp
gene
encod
contain
progli
linker
motif
pvcsp
synthes
gene
name
mlc
encod
total
amino
acid
recombin
gene
modifi
regard
codon
usag
optim
gene
express
brassica
napu
ti
plasmid
induc
gene
transfer
system
use
mlc
chimer
recombin
gene
express
b
napu
gene
express
confirm
polymeras
chain
reaction
pcr
betaglucuronidas
report
gene
gu
assay
western
blot
mlc
chimer
recombin
protein
express
b
napu
molecular
weight
approxim
kda
exhibit
clinic
sensit
n
clinic
specif
n
assess
enzymelink
immunosorb
assay
elisa
oral
immun
balbc
mice
mlc
chimer
recombin
protein
success
induc
antigenspecif
product
addit
cytokin
tnf
significantli
increas
spleen
balbc
mice
chimer
mlc
recombin
protein
produc
b
napu
potenti
antigen
diagnosi
valuabl
vaccin
candid
oral
immun
vivax
malaria
plasmodium
vivax
caus
agent
relaps
benign
tertian
malaria
second
import
malariacaus
speci
afflict
sever
hundr
million
peopl
annual
malaria
constitut
major
health
problem
close
associ
socioeconom
burden
mani
temper
tropic
countri
malaria
situat
korea
peninsula
also
differ
countri
reemerg
earli
two
decadelong
absenc
follow
govern
intervent
report
case
malaria
decreas
cours
sever
year
howev
unlik
malaria
complet
erad
korea
steadi
influx
travel
worker
countri
malaria
endem
appear
fail
treatment
case
also
possibl
therefor
vaccin
develop
need
erad
vivax
malaria
korea
compar
plasmodium
falciparum
vaccin
develop
less
progress
made
develop
vivax
malari
vaccin
due
lower
mortal
associ
vivax
malaria
limit
cultur
p
vivax
vitro
vaccin
prevent
vivax
malaria
need
prevent
morbid
associ
diseas
also
prevent
potenti
spread
malaria
due
reactiv
p
vivax
hypnozoit
nonendem
area
associ
dormant
liver
stage
infect
reactiv
week
month
primari
infect
symptomat
diseas
studi
multistag
plantbas
vaccin
contain
p
vivax
merozoit
surfac
progli
linker
motif
p
vivax
circumsporozoit
protein
pvcsp
gene
encod
kda
glycoprotein
major
merozoit
surfac
protein
sever
plasmodium
speci
thoroughli
investig
vaccin
candid
asexu
blood
stage
malaria
pvcsp
sporozoit
stage
surfac
antigen
consist
short
repeat
sequenc
flank
prerepeat
postrepeat
area
across
global
isol
nine
amino
acid
tandem
repeat
primarili
gdra
da
gqpa
subtyp
gnga
ag
gqaa
subtyp
csp
korean
p
vivax
isol
also
shown
contain
nine
amino
acid
tandem
repeat
sequenc
region
contain
tandem
repeat
clone
make
recombin
protein
subsequ
use
malaria
diagnosi
patient
seroepidemiolog
investig
product
monoclon
antibodi
addit
recombin
protein
report
viabl
vaccin
candid
assess
immunogen
sinc
introduct
vaccin
product
use
transgen
plant
mason
et
al
oral
immunogen
demonstr
sever
antigen
deriv
human
anim
pathogen
express
transgen
plant
exampl
hepat
b
surfac
antigen
express
potato
viral
peptid
vaccin
express
arabidopsi
msp
antigen
p
falciparum
plasmodium
yoelii
express
tobacco
addit
oral
immun
edibl
vaccin
produc
transgen
plant
may
stimul
immun
respons
target
pathogen
howev
commerci
avail
vaccin
base
transgen
plant
yet
produc
studi
antigen
chimer
recombin
protein
express
transgen
brassica
napu
investig
evalu
edibl
vaccin
candid
vivax
malaria
patient
exhibit
clinic
sign
malaria
infect
public
health
center
gimposi
pajusi
gyeonggido
south
korea
examin
malaria
parasit
approxim
ml
blood
collect
symptomat
patient
thin
thick
blood
smear
prepar
microscop
examin
magnif
blood
sampl
transport
korean
nation
institut
health
knih
sera
separ
store
futur
examin
inform
consent
obtain
patient
sampl
collect
human
use
protocol
review
approv
human
ethic
committe
korean
nation
institut
health
cheongwon
korea
chimer
recombin
protein
design
biphas
antigen
target
blood
earli
liver
cell
stage
p
vivax
infect
one
epitop
use
current
studi
deriv
gene
p
vivax
belem
isol
encompass
nucleotid
bp
correspond
interspeci
conserv
block
genbank
access
nucleotid
sequenc
gene
modifi
optim
express
plant
shown
figur
epitop
synthes
four
repeat
gdraagq
pa
express
pvcsp
subtyp
pvcsp
subtyp
link
via
progli
repeat
motif
linker
region
contain
five
six
progli
repeat
surround
intern
sequenc
amino
acid
tlqtridefg
figur
construct
codonoptim
chimer
gene
complementari
strand
oligonucleotid
linker
pvcsp
synthes
xbai
site
end
bamhi
site
end
pvcsp
synthes
oligonucleotid
link
ligas
order
mlc
gene
clone
clone
vector
invitrogen
co
carlsbad
ca
usa
subsequ
transform
escherichia
coli
accord
manufactur
instruct
result
transform
confirm
digest
ecori
plasmid
purifi
digest
xbai
bamhi
restrict
enzym
gene
fragment
insert
protein
express
vector
vector
nexgen
co
seoul
korea
strong
constitut
cauliflow
mosaic
viru
promot
betaglucuronidas
gu
report
gene
neomycin
resist
gene
figur
result
plasmid
amplifi
e
coli
transform
select
regener
transgen
plant
brassica
napu
use
host
plant
transform
plant
cultiv
perform
greenhous
condit
transgen
plant
obtain
use
cotyledon
agrobacteri
transform
techniqu
acquir
cotyledon
explant
seed
germin
cultur
room
photoperiod
h
h
dark
day
light
suppli
coolwhit
daylight
fluoresc
light
seed
medium
contain
murashig
skoog
medium
gamborg
vitamin
salt
wv
sucros
nmorpholino
ethanesulfon
acid
me
plant
agar
cotyledon
explant
excis
vitro
grown
seedl
cut
cm
piec
apic
shoot
tip
remov
agrobacterium
tumefacien
use
infect
cocultiv
grown
yeast
extract
pepton
yep
media
yeast
extract
pepton
sucros
ph
kanamycin
overnight
optic
densiti
nm
cotyledon
immers
infect
media
ml
liquid
infect
medium
consist
salt
sucros
ml
dimethyl
sulfoxid
dmso
ml
pellet
agrobacterium
cultur
incub
min
excess
bacteri
cultur
remov
blot
filter
paper
cotyledon
cocultiv
filter
papercov
cocultur
medium
me
plant
agar
infect
medium
two
day
plate
transfer
dark
condit
day
cotyledon
place
select
medium
consist
salt
wv
sucros
me
ba
acet
acid
naa
plant
agar
supplement
kanamycin
select
pressur
carbenicillin
elimin
agrobacterium
silver
nitrat
prevent
cell
necrosi
callus
select
medium
incub
transfer
fresh
medium
everi
two
week
select
medium
use
shoot
regener
medium
gusposit
explant
regener
shoot
elong
cm
length
transfer
root
medium
approxim
week
later
green
shoot
approxim
cm
length
isol
place
magenta
box
sigma
st
loui
mo
usa
contain
root
medium
carbenicillin
kanamycin
concentr
shoot
regener
medium
root
initi
observ
within
two
three
week
root
develop
matur
plant
within
one
month
regener
shoot
subject
histochem
analysi
gu
express
identif
gu
activ
perform
use
xgluc
histochem
substrat
shoot
g
incub
xgluc
solut
mm
potassium
ferroand
ferricyanid
triton
mm
xgluc
dissolv
dimethylformamid
h
gusposit
respons
reveal
greenbluecolor
solut
wherea
neg
signal
indic
yellowcolour
solut
gu
activ
measur
compar
optic
densiti
wild
type
plant
use
neg
control
transgen
plant
empti
vector
use
posit
control
transgen
plant
target
product
dna
extract
mg
leav
homogen
extract
buffer
contain
mm
trishcl
ph
mm
nacl
mm
ethylenediaminetetraacet
acid
edta
sodium
dodecyl
sulfat
sd
mixtur
transfer
ml
tube
agit
centrifug
supernat
collect
combin
chloroform
isoamyl
alcohol
vv
vortex
centrifug
supernat
precipit
equal
volum
isopropanol
pellet
wash
twice
ethanol
wash
pellet
dissolv
te
buffer
mm
trishcl
mm
edta
ph
dna
sampl
verifi
electrophoresi
agaros
gel
extract
plant
genom
dna
use
templat
polymeras
chain
reaction
pcr
regener
plant
transform
tumefacien
harbour
plasmid
contain
nptii
mlc
gene
identifi
pcr
analysi
pcr
analysi
perform
reaction
mixtur
contain
approxim
genom
plant
dna
follow
condit
min
cycl
min
min
min
final
extens
min
techn
pcr
thermocycl
burlington
nj
usa
pcr
product
obtain
use
primer
set
specif
mlc
gene
mlcf
mlcr
nptii
gene
nptiif
nptiir
respect
confirm
nucleotid
sequenc
plasmid
dna
tumefacien
pcr
product
transgen
plant
genom
dna
sampl
analyz
bionic
inc
seoul
korea
prepar
plant
protein
extract
enzymelink
immnunosorb
assay
western
blot
analysi
plant
tissu
sampl
frozen
liquid
nitrogen
ground
homogen
extract
buffer
trichloroacet
acid
tca
aceton
g
fresh
plant
tissu
ml
buffer
use
extract
place
min
centrifug
g
min
supernat
discard
remain
white
pellet
wash
twice
ml
aceton
plant
protein
extract
separ
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
protein
transfer
onto
polyvinyliden
fluorid
pvdf
membran
use
semidri
transfer
method
biorad
hercul
ca
usa
western
blot
analysi
membran
probe
antibodi
direct
joongkyem
antibodi
therapeut
shiheung
korea
pvcsp
support
wirtz
ra
cdc
usa
wild
type
empti
vectorinsert
transgen
plant
use
neg
control
fifteen
male
balbc
mice
age
six
week
orient
bio
inc
seongnam
korea
divid
three
group
group
mice
fed
g
ground
leav
nontransgen
b
napu
dissolv
ml
pb
group
b
mice
fed
ground
leav
mlctransgen
b
napu
group
c
mice
fed
g
ground
leav
mlctransgen
b
napu
mice
provid
food
water
ad
libitum
howev
mice
fast
overnight
oral
administr
recombin
protein
oral
administr
perform
twice
fourweek
interv
three
week
last
oral
feed
mice
sacrif
spleen
blood
sampl
taken
sera
analyz
elisa
cytokin
immunoglobulin
subtyp
assay
mous
experi
perform
follow
protocol
approv
kyung
hee
univers
institut
anim
care
use
committe
sera
patient
infect
p
vivax
analyz
presenc
antigenspecif
antibodi
use
plate
coat
overnight
per
well
purifi
mlc
chimer
recombin
protein
dissolv
phosphat
buffer
salin
pb
ph
patient
serum
sampl
dilut
vv
block
buffer
pbstween
bovin
serum
albumin
ph
ad
plate
incub
h
wash
well
pbstween
solut
three
time
plate
incub
peroxidaseconjug
goat
antihuman
igg
secondari
antibodi
dilut
vv
sigma
color
develop
acid
abt
peroxidas
substrat
kirkegaard
perri
laboratori
gaithersburg
md
usa
ad
well
incub
room
temperatur
min
absorb
mixtur
measur
nm
molecular
devic
sunnyval
ca
usa
cutoff
valu
taken
mean
standard
deviat
neg
sampl
spleen
oral
immun
mice
minc
razor
ad
ml
ice
cold
endotoxinfre
pb
contain
proteas
inhibitor
cocktail
roch
igep
nonion
deterg
sigma
spleen
lysat
centrifug
g
min
supernat
collect
store
cytokin
analysi
presenc
tnf
spleen
lysat
determin
use
bioplex
kit
biorad
accord
manufactur
protocol
result
analyz
use
bioplex
manag
softwar
biorad
analyz
isotyp
antibodi
produc
oral
immun
mous
immunoglobulin
isotyp
kit
millipor
billerica
usa
use
briefli
sera
collect
week
final
immun
dilut
milliplex
map
assay
buffer
vv
serum
concentr
antibodi
isotyp
iga
igm
measur
luminex
luminex
austin
tx
usa
data
present
mean
standard
deviat
result
statist
analyz
tnf
level
among
three
group
compar
use
oneway
anova
follow
bonferroni
multipl
comparison
test
pvalu
consid
statist
signific
mlc
chimer
recombin
gene
synthes
use
p
vivax
gene
nine
tandem
repeat
p
vivax
subtyp
csp
gene
gene
modifi
optim
gene
express
plant
without
chang
amino
acid
codon
usag
shown
figur
follow
optim
synthet
gene
sequenc
reveal
ident
belem
isol
p
vivax
figur
linker
region
contain
six
progli
repeat
five
intern
sequenc
amino
acid
tlqtridefg
figur
last
g
progli
repeat
overlap
start
csp
repeat
repeat
sequenc
pvcsp
ad
linker
region
two
gdgaagqaa
two
gdraagqpa
sequenc
result
synthet
mlc
chimer
recombin
gene
name
mlc
gene
compos
amino
acid
linker
amino
acid
tandem
repeat
pvcsp
subtyp
figur
mlc
chimer
recombin
gene
insert
vector
xbai
bamhi
site
express
b
napu
result
express
vector
refer
transform
b
napu
use
agrobacteriummedi
dna
deliveri
system
figur
three
transgen
plant
group
construct
group
nontransgen
plant
wild
type
group
ii
plant
transform
tumefacien
empti
plasmid
neg
control
group
iii
plant
transform
tumefacien
nontransgen
plant
show
yellow
color
gu
assay
figur
optic
densiti
n
figur
b
napu
plant
transform
tumefacien
plasmid
produc
callus
exhibit
green
spot
gu
report
gene
assay
figur
optic
densiti
n
figur
result
indic
presenc
target
plasmid
plant
callus
obtain
transgen
b
napu
plant
tumefacien
show
posit
respons
gu
report
gene
assay
figur
optic
densiti
n
figur
gu
report
geneexpress
plant
posit
screen
presenc
recombin
gene
pcr
analysi
pcr
product
amplifi
mlc
specif
primer
consist
includ
expect
band
mlc
transform
plant
pcr
nontransform
plant
fail
amplifi
target
mlc
gene
pcr
analysi
use
nptiispecif
primer
set
show
product
approxim
bp
figur
dna
sequenc
analysi
genom
dna
transgen
b
napu
plant
demonstr
ident
sequenc
mlc
chimer
recombin
gene
investig
antigen
mlc
chimer
recombin
protein
express
b
napu
protein
purifi
use
tcaacetonebas
protein
precipit
method
sdspage
analysi
determin
molecular
mass
protein
approxim
kda
figur
lane
shown
figur
recombin
protein
react
lane
antipvcsp
antibodi
lane
protein
exhibit
clinic
sensit
n
specif
n
elisa
figur
therefor
mlc
chimer
recombin
protein
display
antigen
properti
vitro
serum
sampl
collect
group
mice
three
week
final
immun
test
mlc
chimer
recombin
proteinspecif
antibodi
use
western
blot
analysi
antigenspecif
antibodi
detect
pb
fed
mice
figur
mice
figur
howev
two
five
mice
fed
mlc
chimer
recombin
protein
show
posit
reaction
western
blot
figur
isotyp
analysi
level
increas
sera
balbc
mice
fed
extract
transform
b
napu
mean
amount
express
spleen
pgml
group
mice
fed
pb
pgml
group
mice
fed
b
napu
transform
empti
express
vector
pgml
group
mice
fed
b
napu
express
mlc
chimer
recombin
protein
signific
differ
group
figur
mean
amount
express
pgml
group
pgml
group
pgml
group
signific
differ
group
group
statist
signific
differ
group
p
figur
mean
amount
express
pgml
group
pgml
group
pgml
group
signific
differ
group
group
statist
signific
differ
group
p
figur
mean
amount
express
pgml
group
pgml
group
pgml
group
signific
differ
group
group
group
p
figur
therefor
cytokin
tnf
express
spleen
balbc
mice
oral
immun
ground
leav
transgen
plant
express
mlc
chimer
recombin
protein
number
malari
protein
demonstr
potenti
vaccin
candid
current
variou
stage
preclin
clinic
trial
mani
trial
base
msp
csp
apic
membran
protein
vast
major
vaccin
candid
target
p
falciparum
fewer
p
vivax
candid
vaccin
develop
present
two
p
vivax
subunit
vaccin
candid
undergo
clinic
develop
modest
number
candid
preclin
trial
addit
sever
trial
chimer
malaria
vaccin
construct
use
howev
although
chimer
vaccin
success
induc
high
antibodi
respons
fail
protect
infecti
challeng
parasit
present
studi
mlc
chimer
recombin
protein
develop
contain
region
four
tandemli
repeat
sequenc
nine
amino
acid
csp
subtyp
strategi
gene
construct
first
challeng
make
mlc
chimer
recombin
protein
multistag
combin
vaccin
direct
merozoit
sporozoit
form
b
napu
select
express
mlc
chimer
recombin
gene
express
purif
recombin
protein
plant
sever
advantag
compar
commerci
express
system
first
plantbas
vaccin
contain
endotoxin
produc
bacteri
cultur
purif
step
addit
biomass
produc
plant
greater
system
therebi
reduc
cost
allow
rapid
industri
manufactur
also
edibl
plant
util
plantbas
vaccin
eaten
raw
without
modif
factori
final
express
candid
vaccin
protein
plant
allow
complet
synthesi
target
antigen
abl
induc
activ
immun
respons
anim
light
advantag
transgen
plant
gener
investig
use
product
vaccin
variou
human
pathogen
studi
employ
classic
techniqu
gener
transgen
b
napu
produc
transgen
plant
contain
mlc
chimer
recombin
protein
gene
control
constitut
promot
addit
nucleotid
sequenc
region
modifi
optim
express
plant
figur
modifi
sequenc
nucleotid
sequenc
homolog
amino
acid
sequenc
homolog
compar
origin
sequenc
p
vivax
belem
isol
success
express
b
napu
figur
lane
purifi
mlc
chimer
recombin
protein
react
well
sera
vivax
malaria
patient
figur
therefor
reagent
could
use
serodiagnos
patient
vivax
malaria
although
mice
oral
immun
g
mlc
chimer
recombin
protein
produc
antigenspecif
antibodi
mlc
chimer
recombin
proteinspecif
antibodi
detect
two
five
mice
figur
observ
indic
mlc
chimer
recombin
protein
possibl
trigger
immun
respons
tnf
detect
spleen
balbc
mice
oral
immun
mlc
chimer
recombin
protein
figur
howev
produc
signific
amount
togeth
result
mlc
chimer
recombin
protein
induc
immun
respons
balbc
mice
effect
base
work
mlc
chimer
recombin
protein
produc
transgen
b
napu
plant
potenti
p
vivax
vaccin
candid
sever
merit
uniqu
b
napu
product
antimalari
vaccin
includ
eas
cultiv
b
napu
even
absenc
certain
nutrient
lee
et
al
malaria
journal
http
togeth
advantag
allow
rapid
industri
manufactur
addit
conveni
ingest
plant
popul
given
vaccin
part
routin
diet
strategi
decreas
cost
vaccin
malaria
develop
countri
addit
trial
develop
edibl
plant
vaccin
contribut
basic
understand
develop
vivax
malaria
vaccin
conclus
mlc
chimer
recombin
protein
might
help
serodiagnosi
vaccin
develop
p
vivax
